A recent review of the randomised controlled trials literature concluded that while B vitamin supplementation consistently lowers homocysteine, the clinical benefit for thrombosis prevention remains uncertain (5)
GLP-1 medications are changing how people think about weight loss and how they actually lose weight, driving changes in views about obesity care among health systems and providers and affecting the broader US economy
While less common, some side effects are more serious and should be taken seriously
Based on these metabolic features, we investigated whether this probiotic strain could augment the weight-lowering effects of the GLP-1 RA dulaglutide, preserve muscle mass during weight reduction, and mitigate the weight regain and glycemic deterioration typically observed after treatment withdrawal, reads the study
Clinical perspective SGLT2is and GLP-1RAs exhibit clinical benefits on glycemic control, systolic blood pressure (SBP), body weight, and dyslipidemia, which may all partly contribute to the cardiovascular protection provided by these two drug classes [4, 19]
